Ondansetron Hydrochloride/Olanzapine

盐酸昂丹司琼/奥氮平

Report date: 2022/03/14 11:34:07

Base Information

Drug NameOndansetron Hydrochloride/Olanzapine
Drug Alias Name昂丹司琼奥氮平Ondansetron/olanzapine昂丹司琼/奥氮平Olanzapine and OndansetronOndansetron and olanzapine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonistsDopamine D1 receptor antagonistsDopamine D2 receptor antagonists +[4] 
TargetsSerotonin 3 (5-HT3) receptorDopamine D1 receptorDopamine D2 receptor +[4] 
Therapy Area/IndicationsAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Ondansetron HydrochlorideOlanzapine
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTranscept Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTranscept Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAlcoholism

Other Information

ATC CodeN/A
Related LinksN/A